➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
McKinsey
Moodys
Merck
Baxter

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Caprylic acid


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Caprylic acid?

Caprylic acid is an investigational drug.

There have been 5 clinical trials for Caprylic acid. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2017.

The most common disease conditions in clinical trials are Peripheral Nervous System Diseases, Diabetic Neuropathies, and Tremor. The leading clinical trial sponsors are Accera, Inc., Celerion, and University of British Columbia.

There is one US patent protecting this investigational drug and eighteen international patents.

Recent Clinical Trials for Caprylic acid
TitleSponsorPhase
Topical Menthol +/- Mannitol for Painful Diabetic Peripheral NeuropathyUniversity of British ColumbiaPhase 1/Phase 2
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionCelerionPhase 1
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionAccera, Inc.Phase 1

See all Caprylic acid clinical trials

Clinical Trial Summary for Caprylic acid

Top disease conditions for Caprylic acid
Top clinical trial sponsors for Caprylic acid

See all Caprylic acid clinical trials

US Patents for Caprylic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Caprylic acid   Start Trial Heterocyclic compounds useful in the treatment of disease Epigen Biosciences, Inc. (San Diego, CA)   Start Trial
Caprylic acid   Start Trial Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers eFFECTOR Therapeutics, Inc. (San Diego, CA)   Start Trial
Caprylic acid   Start Trial Preparation of poly alpha-1,3-glucan esters and films therefrom E I DU PONT DE NEMOURS AND COMPANY (Wilmington, DE)   Start Trial
Caprylic acid   Start Trial Glycolurils having functional groups and use thereof SHIKOKU CHEMICALS CORPORATION (Kagawa, JP)   Start Trial
Caprylic acid   Start Trial Hybrid material for optoelectronic applications AZ Electronic Materials (Luxembourg) S.a.r.l. (Luxembourg, LU)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Caprylic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Caprylic acid Australia 2014232383 2033-03-15   Start Trial
Caprylic acid Australia 2019202731 2033-03-15   Start Trial
Caprylic acid Brazil 112015023267 2033-03-15   Start Trial
Caprylic acid Canada 2906931 2033-03-15   Start Trial
Caprylic acid Canada 3046894 2033-03-15   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Dow
Baxter
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.